Federal Register of Legislation - Australian Government

Primary content

Therapeutic Goods Amendment Regulations 2000 (No. 6)

Authoritative Version
  • - F2000B00279
  • No longer in force
SR 2000 No. 267 Regulations as made
These Regulations amend the Therapeutic Goods Regulations 1990.
Administered by: Health
General Comments: This instrument was backcaptured in accordance with Section 36 of the Legislative Instruments Act 2003
Registered 01 Jan 2005
Tabling HistoryDate
Tabled HR03-Oct-2000
Tabled Senate03-Oct-2000
Gazetted 28 Sep 2000
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

Therapeutic Goods Amendment Regulations 2000 (No. 6)1

Statutory Rules 2000 No. 2672

I, WILLIAM PATRICK DEANE, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the Therapeutic Goods Act 1989.

Dated 27 September 2000

WILLIAM DEANE

Governor-General

By His Excellency’s Command

GRANT TAMBLING


1              Name of Regulations

                These Regulations are the Therapeutic Goods Amendment Regulations 2000 (No. 6).

2              Commencement

                These Regulations commence on gazettal.

3              Amendment of Therapeutic Goods Regulations 1990

                Schedule 1 amends the Therapeutic Goods Regulations 1990.


Schedule 1        Amendments

  

(regulation 3)

[1]         After regulation 43AA

insert

43AB      Circumstances in which inspection fee covered by annual charge

         (1)   A fee is not payable in accordance with item 9AB of Schedule 9 for an inspection covered by the annual charge for a licence to manufacture the therapeutic goods mentioned in that item.

         (2)   An inspection is covered by the annual charge for a licence to manufacture the therapeutic goods if no more than 2 prior inspections have been carried out at the metropolitan site, identified in the licence, within the period of 3 years immediately preceding the relevant inspection.

         (3)   In this regulation:

inspection means an inspection in relation to a metropolitan site.

[2]         Paragraph 45 (4A) (c)

omit

reduced by

insert

reduced to

[3]         Regulation 45A

omit

If the wholesale turnover

insert

         (1)   Subject to subregulation (2), if the wholesale turnover

[4]         Regulation 45A

insert

         (2)   Subregulation (1) does not apply in relation to the annual charge payable in respect of a licence that is in force for the manufacture of human blood and blood components.

[5]         Schedule 9, item 9, paragraph (a)

omit

within Australia

insert

within Australia (except for therapeutic goods mentioned in items 9AB and 9AC)

[6]         Schedule 9, item 9A

substitute

9A

fee for paragraph 25 (1) (g) or (h), or 26 (1) (g) or (h) of the Act (and, in relation to associated inspections, for paragraphs 38 (1) (c), 41 (1) (f) and  58 (3) (b) of the Act), in respect of the evaluation of steps in the manufacture of therapeutic goods (except in relation to goods mentioned in item 9AD), by reference to data in relation to premises where manufacture of the goods takes place, being data contained in a file known as the plant master file

5 625

9AB

fee for inspection (including an inspection for paragraph  58 (3) (b) of the Act) of manufacturing premises or operations for the preparation of human blood and blood components under licence, at the metropolitan site covered by the licence, for each inspector engaged per hour, or part of an hour

500

9AC

fee for inspection (including an inspection for paragraph  58 (3) (b) of the Act) of manufacturing premises or operations for the preparation of human blood and and blood components under licence, at a site covered by the licence other than the metropolitan site, for each inspector engaged per hour, or part of an hour

355

9AD

fee for paragraph 25 (1) (g) or (h), or 26 (1) (g) or (h) of the Act (and, in relation to associated inspections, for paragraphs 38 (1) (c), 41 (1) (f) and  58 (3) (b) of the Act), in respect of the evaluation of the manufacture of human blood and blood components prepared under licence by reference to data contained in files known as technical master files or plasma master files, where the total number of pages of each file referred to is:

 

 

   (a)  not over 10 pages

725

 

  (b)  over 10 pages, but not over 50 pages

6 200

 

   (c)  over 50 pages, but not over 100 pages

13 750

 

  (d)  over 100 pages, but not over 1 000 pages

18 500

 

   (e)  over 1 000 pages, but not over 3 000 pages

 

29 000

 

   (f)  over 3 000 pages, but not over 4 000 pages

 

38 500

 

   (g)  over 4 000 pages

47 000

Notes

1.       These Regulations amend Statutory Rules 1990 No. 394, as amended by 1991 Nos. 84 and 485; 1992 Nos. 19, 89, 109, 332, 370 and 430; 1993 No. 141; 1994 Nos. 150, 222 and 364; 1995 Nos. 33, 111, 192, 208, 253, 320 and 328; 1996 Nos. 9, 25 (disallowed by the House of Representatives on 10 September 1996), 131, 200 and 208; 1997 Nos. 162, 398, 399, 400 and 401 (disallowed by the Senate on 31 March 1998); 1998 Nos. 227, 247 and 369; 1999 Nos. 62, 209 and 324; 2000 Nos. 29, 48, 70, 123 and 124.

2.       Notified in the Commonwealth of Australia Gazette on 28 September 2000.